Retrieve available abstracts of 31 articles: HTML format
Single Articles
May 2025
LI H, Song M, Hylemon PB, Zhou H, et al LECT2-PHB2 axis: a new mechanistic insight and therapeutic opportunity in
alcohol-associated hepatitis.
Gut. 2025 May 13:gutjnl-2025-335259. doi: 10.1136/gutjnl-2025-335259. PubMed
April 2025
ROTTELE F, Zollner A, Mogler C, Yuksel M, et al Characteristic immune cell interactions in livers of children with acute
hepatitis revealed by spatial single-cell analysis identify a possible postacute
sequel of COVID-19.
Gut. 2025 Apr 5:gutjnl-2024-333880. doi: 10.1136/gutjnl-2024-333880. PubMedAbstract available
LURJE I, Tacke F Immune pathology in paediatric acute hepatitis of unknown origin - uncovering the
link to COVID-19.
Gut. 2025 Apr 5:gutjnl-2024-334453. doi: 10.1136/gutjnl-2024-334453. PubMed
GLEESON D, Bornand R, Brownlee A, Dhaliwal H, et al British Society of Gastroenterology guidelines for diagnosis and management of
autoimmune hepatitis.
Gut. 2025 Apr 1:gutjnl-2024-333171. doi: 10.1136/gutjnl-2024-333171. PubMedAbstract available
March 2025
XU H, Wu Z, Qin J, Li X, et al Stressed hepatocyte sustains alcohol-associated hepatitis progression by
producing leukocyte cell-derived chemotaxin 2.
Gut. 2025 Mar 26:gutjnl-2024-334318. doi: 10.1136/gutjnl-2024-334318. PubMedAbstract available
RODRIGO-TORRES D, Kilpatrick AM, Ferreira-Gonzalez S, Aird RE, et al Longitudinal paired liver biopsies and transcriptome profiling in
alcohol-associated hepatitis reveal dynamic changes in cellular senescence.
Gut. 2025 Mar 23:gutjnl-2024-334094. doi: 10.1136/gutjnl-2024-334094. PubMedAbstract available
December 2024
LAMPERTICO P, Anolli MP, Roulot D, Wedemeyer H, et al Antiviral therapy for chronic hepatitis delta: new insights from clinical trials
and real-life studies.
Gut. 2024 Dec 11:gutjnl-2024-332597. doi: 10.1136/gutjnl-2024-332597. PubMedAbstract available
October 2024
PAN DZ, Soulette CM, Aggarwal A, Han D, et al Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver
immune microenvironment in patients with chronic hepatitis B.
Gut. 2024 Oct 8:gutjnl-2024-332526. doi: 10.1136/gutjnl-2024-332526. PubMedAbstract available
LIU T, Li J, Yin X, Lu F, et al Establishment of enterically transmitted hepatitis virus animal models using
lipid nanoparticle-based full-length viral genome RNA delivery system.
Gut. 2024 Oct 1:gutjnl-2024-332784. doi: 10.1136/gutjnl-2024-332784. PubMedAbstract available
September 2024
BROL MJ, Canbay A, Trebicka J Alcohol-associated hepatitis: a neutrophile disease?
Gut. 2024 Sep 24:gutjnl-2024-333222. doi: 10.1136/gutjnl-2024-333222. PubMed
MAK LY, Wooddell CI, Lenz O, Schluep T, et al Long-term hepatitis B surface antigen response after finite treatment of ARC-520
or JNJ-3989.
Gut. 2024 Sep 12:gutjnl-2024-333026. doi: 10.1136/gutjnl-2024-333026. PubMedAbstract available
FAN R, Zhao S, Niu J, Ma H, et al High accuracy model for HBsAg loss based on longitudinal trajectories of serum
qHBsAg throughout long-term antiviral therapy.
Gut. 2024;73:1725-1736. PubMedAbstract available
July 2024
VECCHI A, Rossi M, Tiezzi C, Fisicaro P, et al HBcrAg values may predict virological and immunological responses to pegIFN-alpha in
NUC-suppressed HBeAg-negative chronic hepatitis B.
Gut. 2024 Jul 20:gutjnl-2024-332290. doi: 10.1136/gutjnl-2024-332290. PubMedAbstract available
KREIMEYER H, Gonzalez CG, Fondevila MF, Hsu CL, et al Faecal proteomics links neutrophil degranulation with mortality in patients with
alcohol-associated hepatitis.
Gut. 2024 Jul 20:gutjnl-2024-332730. doi: 10.1136/gutjnl-2024-332730. PubMedAbstract available
BAUMERT T, Urbanek-Quaing M, Cornberg M Immunomodulation and entry inhibition: selgantolimod's double punch against
hepatitis B virus.
Gut. 2024 Jul 5:gutjnl-2024-332679. doi: 10.1136/gutjnl-2024-332679. PubMed
KAMAR N, Marion O, Abravanel F, Esposito L, et al Porcine-derived pancreatic enzyme replacement therapy: a cause of hepatitis E
virus transmission?
Gut. 2024 Jul 2:gutjnl-2024-332744. doi: 10.1136/gutjnl-2024-332744. PubMed
June 2024
ZHOU J, Liu K, Pan Q Porcine-derived pancreatic enzyme replacement therapy linking to chronic
hepatitis E: broad implications.
Gut. 2024 Jun 12:gutjnl-2024-332975. doi: 10.1136/gutjnl-2024-332975. PubMed
May 2024
FRERICKS N, Kinast V, Steinmann E Potential risk of porcine-derived pancreatic enzyme medication for the
cross-species transmission of hepatitis E virus.
Gut. 2024 May 31:gutjnl-2024-332577. doi: 10.1136/gutjnl-2024-332577. PubMed
VO-QUANG E, Pawlotsky JM 'Unusual' HCV genotype subtypes: origin, distribution, sensitivity to
direct-acting antiviral drugs and behaviour on antiviral treatment and
retreatment.
Gut. 2024 May 23:gutjnl-2024-332177. doi: 10.1136/gutjnl-2024-332177. PubMedAbstract available
ROCA SUAREZ AA, Plissonnier ML, Grand X, Michelet M, et al TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and
impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.
Gut. 2024 May 2:gutjnl-2023-331396. doi: 10.1136/gutjnl-2023-331396. PubMedAbstract available
April 2024
THORNTON CS, Waddell BJ, Congly SE, Svishchuk J, et al Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic
hepatitis E virus infection in cystic fibrosis lung transplant recipients.
Gut. 2024 Apr 15:gutjnl-2023-330602. doi: 10.1136/gutjnl-2023-330602. PubMedAbstract available
January 2024
HE T, Zhang D Non-linear association of baseline viral load with on-treatment hepatocellular
carcinoma risk in chronic hepatitis B: still needs further discussion.
Gut. 2024 Jan 22:gutjnl-2023-331443. doi: 10.1136/gutjnl-2023-331443. PubMed
Correction: Hepatitis C reference viruses highlight potent antibody responses and
diverse viral functional interactions with neutralising antibodies.
Gut. 2024;73:e1. PubMed
LIN C, Luo L, Xun Z, Zhu C, et al Novel function of MOTS-c in mitochondrial remodelling contributes to its
antiviral role during HBV infection.
Gut. 2024;73:338-349. PubMedAbstract available
November 2023
WANG Y, Li Q, Li C, Wang C, et al Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface
antigen secretion.
Gut. 2023 Nov 16:gutjnl-2023-330537. doi: 10.1136/gutjnl-2023-330537. PubMedAbstract available
YU X, Gong Q, Yu D, Chen Y, et al Spatial transcriptomics reveals a low extent of transcriptionally active
hepatitis B virus integration in patients with HBsAg loss.
Gut. 2023 Nov 15:gutjnl-2023-330577. doi: 10.1136/gutjnl-2023-330577. PubMedAbstract available
October 2023
TESTONI B, Scholtes C, Plissonnier ML, Paturel A, et al Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in
untreated and NUC treated patients with chronic hepatitis B.
Gut. 2023 Oct 25:gutjnl-2023-330644. doi: 10.1136/gutjnl-2023-330644. PubMedAbstract available
CHOI WM, Kim GA, Choi J, Choi GH, et al Non-linear association of baseline viral load with on-treatment hepatocellular
carcinoma risk in chronic hepatitis B.
Gut. 2023 Oct 9:gutjnl-2023-330225. doi: 10.1136/gutjnl-2023-330225. PubMedAbstract available
LIU Z, Lin C, Mao X, Guo C, et al Changing prevalence of chronic hepatitis B virus infection in China between 1973
and 2021: a systematic literature review and meta-analysis of 3740 studies and
231 million people.
Gut. 2023 Oct 5:gutjnl-2023-330691. doi: 10.1136/gutjnl-2023-330691. PubMedAbstract available
September 2023
LE BERT N, Fisicaro P Enolase: a metabolic checkpoint behind diverse exhaustion stages of CD8+ T cells
in chronic HBV and HCV.
Gut. 2023 Sep 6:gutjnl-2023-330541. doi: 10.1136/gutjnl-2023-330541. PubMed
January 2023
HENDRIKX T, Lang S, Rajcic D, Wang Y, et al Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and
prevents ethanol-induced liver disease in mice.
Gut. 2023 Jan 23:gutjnl-2022-328265. doi: 10.1136/gutjnl-2022-328265. PubMedAbstract available